Development Scientist I
Danaher Corporation
Summary
The Research and Development department is seeking a Development Scientist I to support the operation of the Development Pilot Lab. The Pilot Lab serves as a bridge between Research & Development and Manufacturing by supporting the production, transfer, and troubleshooting of development and pilot-scale products. This position is responsible for the routine production and documentation of Development and Pilot material used for verification, validation, and process transfer activities, as well as supporting the manufacturing of Research Use Only (RUO) Biomarker products. The Development Scientist I will assist with technology transfer activities, support troubleshooting efforts, collaborate with cross-functional partners, and contribute to future product and process development initiatives as project priorities and pilot lot schedules allow.
Job description
In this role, you will have the opportunity to:
- Participate in the development and commercialization of immunoassays
- Execute experiments, analyze and present conclusions to teams
- Communicate project status and data generated with cross-functional teams
- Work in a fast-paced environment and maintain timelines for multiple projects
- Work with the development and manufacturing associates to ensure a smooth transition of product transfer into manufacturing
Requirements
- Bachelor's Degree in Life Science (Chemistry, Biology, Microbiology Biology or related science)
- 0+ years of laboratory experience
- Training in Life Sciences (Chemistry, Biochemistry, Biology, Microbiology, or medical related science), Laboratory Medicine, or other related clinical chemistry experience
- Knowledge of good laboratory practices and scientific methods
Benefits
- Paid time off
- Medical insurance
- Dental insurance
- Vision insurance
- 401(k)
Company overview
Danaher Corporation is a leading global science and technology innovator headquartered in Washington, D.C., specializing in biotechnology, life sciences, and diagnostics. Founded in 1984 by brothers Steven and Mitchell Rales, the company has evolved from its origins as a manufacturing conglomerate into a premier healthcare technology organization with approximately 63,000 employees worldwide. Danaher operates through three core divisions: biotechnology (28% of revenues), which develops products for therapeutic development; life sciences (31% of revenues), focused on disease identification, new therapies, and drug testing/manufacturing; and diagnostics (41% of revenues), providing instruments, consumables, and software for disease diagnosis. The company's portfolio includes renowned brands such as Beckman Coulter, Cytiva, Pall Corporation, Cepheid, Leica Microsystems, and Abcam, serving pharmaceutical companies, biotechnology firms, healthcare providers, and research institutions globally. Danaher is distinguished by its Danaher Business System (DBS), a continuous improvement methodology that drives innovation and operational excellence. With 2024 revenues of $23.9 billion, the company ranks 180th on the Fortune 500 and plays a critical role in advancing scientific research, improving diagnostic capabilities, and accelerating the development of life-saving therapies.